Professor, Medicine, University of Colorado School of Medicine
Endocrinology
Dr. Jane E. Reusch, MD
|
|
Give Review
Jane Reusch works in the field of Endocrinology. She graduated from University of Minnesota Medical School. University of Minnesota Medical School has a rank of 40 in research and a 10 in primary care She received 1 awards: "Elected Member". Dr. Jane E. Reusch is also published. She has 91 publications published. The lastest publication: "Insulin-like growth factor I-mediated activation of the transcription factor cAMP response element-binding protein in PC12 cells. Involvement of p38 mitogen-activated ...'
Publications
- Peripheral Insulin Resistance in Obese Girls with Hyperandrogenism is Related to Oxidative Phosphorylation and Elevated Serum Free Fatty Acids.
- Obesity-related pulmonary arterial hypertension in rats correlates with increased circulating inflammatory cytokines and lipids and with oxidant damage in the arterial...
- Renal Function Is Associated With Peak Exercise Capacity in Adolescents With Type 1 Diabetes.
- Saxagliptin Restores Vascular Mitochondrial Exercise Response in the Goto-Kakizaki Rat.
- Efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide (HARMONY 1): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled...
- Delayed skeletal muscle mitochondrial ADP recovery in youth with type 1 diabetes relates to muscle insulin resistance.
- Sex Differences in the Effects of Type 2 Diabetes on Exercise Performance.
- Targeting mitochondria to restore failed adaptation to exercise in diabetes.
- Method for Controlled Mitochondrial Perturbation during Phosphorus MRS in Children.
- Inhibition of Phosphatidylinositol-3-kinase/Akt Signaling Attenuates Hypoxia-Induced Pulmonary Artery Remodeling and Suppresses CREB Depletion in Arterial Smooth Muscl...
- Adipose tissue insulin resistance in adolescents with and without type 2 diabetes.
- Impaired response to exercise intervention in the vasculature in metabolic syndrome.
- Nitric Oxide Regulates Vascular Adaptive Mitochondrial Dynamics.
- Arterial insulin resistance in Yucatan micropigs with diet-induced obesity and metabolic syndrome.
- Type 2 diabetes mellitus and exercise impairment.
- Impaired Contractile Recovery after Low-Flow Myocardial Ischemia in a Porcine Model of Metabolic Syndrome.
- Potential of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosing.
- Nutrition and fat cell differentiation.
- Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic syndrome.
- [Endurance capabilities of triathlon competitors with type 1 diabetes mellitus].
- New directions in treating insulin resistance.
- Preoperative diagnosis of lymphocytic hypophysitis (adenohypophysitis) unresponsive to short course dexamethasone: case report.
- High-performance liquid chromatography of water-soluble vitamins. Part 3. Simultaneous determination of vitamins B1, B2, B6, B12 and C, nicotinamide and folic acid in ...
- Cyclic changes of vitamin D and PTH are primarily regulated by solar radiation: 5-year analysis of a German (50 degrees N) population.
- Content and activity of cAMP response element-binding protein regulate platelet-derived growth factor receptor-alpha content in vascular smooth muscles.
- Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome.
- Oxidative stress-mediated down-regulation of bcl-2 promoter in hippocampal neurons.
- Cytokine-mediated down-regulation of the transcription factor cAMP-response element-binding protein in pancreatic beta-cells.
- SP600125, an inhibitor of c-jun N-terminal kinase, activates CREB by a p38 MAPK-mediated pathway.
- Cyclic AMP response element-binding protein in the vessel wall: good or bad?
- Thiazolidinedione therapy: the benefits of aggressive and early use in type 2 diabetes.
- Diabetes, microvascular complications, and cardiovascular complications: what is it about glucose?
- Cardiovascular risk in women with type 2 diabetes.
- Novel actions of thiazolidinediones on vascular function and exercise capacity.
- Oral L-arginine and vitamins E and C improve endothelial function in women with type 2 diabetes.
- Odorant stimulation enhances survival of olfactory sensory neurons via MAPK and CREB.
- Are low-income elderly patients at risk for poor diabetes care?
- Loss of CREB regulation of vascular smooth muscle cell quiescence in diabetes.
- Time management in academic medicine.
- CREB mediates ERK-induced survival of mouse renal tubular cells after oxidant stress.
- Macrovascular risk factors in patients with diabetes: physician treatment strategies and extent of control.
- Rosiglitazone improves exercise capacity in individuals with type 2 diabetes.
- Exercise training and calorie restriction increase SREBP-1 expression and intramuscular triglyceride in skeletal muscle.
- Diabetes and advanced glycoxidation end products.
- Platelet-derived growth factor BB induces nuclear export and proteasomal degradation of CREB via phosphatidylinositol 3-kinase/Akt signaling in pulmonary artery smooth...
- Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling.
- Restoration of CREB function is linked to completion and stabilization of adaptive cardiac hypertrophy in response to exercise.
- Atherosclerosis in diabetes and insulin resistance.
- Inhibition of cAMP-response element-binding protein activity decreases protein kinase B/Akt expression in 3T3-L1 adipocytes and induces apoptosis.
- Impaired fibrinolysis in premenopausal women and age-matched men with Type 2 diabetes mellitus: a pilot study.
- Skeletal muscle deoxygenation after the onset of moderate exercise suggests slowed microvascular blood flow kinetics in type 2 diabetes.
- Nonesterified fatty acid exposure activates protective and mitogenic pathways in vascular smooth muscle cells by alternate signaling pathways.
- Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-cont...
- Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function.
- Women with type 2 diabetes perceive harder effort during exercise than nondiabetic women.
- Thiazolidinediones prevent PDGF-BB-induced CREB depletion in pulmonary artery smooth muscle cells by preventing upregulation of casein kinase 2 alpha' catalytic subunit.
- CREB downregulation in vascular disease: a common response to cardiovascular risk.
- Cardiovascular function/dysfunction in adolescents with type 1 diabetes.
- Reduction of reactive oxygen species prevents hypoxia-induced CREB depletion in pulmonary artery smooth muscle cells.
- Cardiovascular disease in diabetes: where does glucose fit in?
- Beyond phosphorylation: nuclear export in vascular remodeling.
- WISP1, a pro-mitogenic, pro-survival factor, mediates tumor necrosis factor-alpha (TNF-alpha)-stimulated cardiac fibroblast proliferation but inhibits TNF-alpha-induce...
- Cardiac dysfunction during exercise in uncomplicated type 2 diabetes.
- Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity.
- Discordance between intramuscular triglyceride and insulin sensitivity in skeletal muscle of Zucker diabetic rats after treatment with fenofibrate and rosiglitazone.
- Insulin-like growth factor-I induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein.
- Effects of exercise training on oxygen uptake kinetic responses in women with type 2 diabetes.
- CREB activation induces adipogenesis in 3T3-L1 cells.
- Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein.
- Insulin-induced adipocyte differentiation. Activation of CREB rescues adipogenesis from the arrest caused by inhibition of prenylation.
- cAMP response element-binding protein content is a molecular determinant of smooth muscle cell proliferation and migration.
- Diabetes-related changes in cAMP response element-binding protein content enhance smooth muscle cell proliferation and migration.
- Differential requirement for p21ras activation in the metabolic signaling by insulin.
- Insulin inhibits dephosphorylation of adenosine 3',5'-monophosphate response element-binding protein/activating transcription factor-1: effect on nuclear phosphoserine...
- Reduced phosphorylation of mitogen-activated protein kinase kinase in response to insulin in cells with truncated C-terminal domain of insulin receptor.
- Functional interactions of phosphatidylinositol 3-kinase with GTPase-activating protein in 3T3-L1 adipocytes.
- Insulin stimulates cAMP-response element binding protein activity in HepG2 and 3T3-L1 cell lines.
- Insulin-like growth factor I-mediated activation of the transcription factor cAMP response element-binding protein in PC12 cells. Involvement of p38 mitogen-activated ...
- Role for oxidative stress in the regeneration of islet beta cells?
- Insulin inhibits nuclear phosphatase activity: requirement for the C-terminal domain of the insulin receptor.
- Abnormal oxygen uptake kinetic responses in women with type II diabetes mellitus.
- Regulation of GLUT-4 phosphorylation by intracellular calcium in adipocytes.
- Dominant negative mutant forms of the cAMP response element binding protein induce apoptosis and decrease the anti-apoptotic action of growth factors in human islets.
- GLUT-4 phosphorylation and its intrinsic activity. Mechanism of Ca(2+)-induced inhibition of insulin-stimulated glucose transport.
- Inverse relationship between GLUT-4 phosphorylation and its intrinsic activity.
- Oxidative stress in type 1 diabetes.
- Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes.
- C-reactive protein decreases interleukin-10 secretion in activated human monocyte-derived macrophages via inhibition of cyclic AMP production.
- Focus on insulin resistance in type 2 diabetes: therapeutic implications.
- Cardiopulmonary Dysfunction and Adiponectin in Adolescents With Type 2 Diabetes.
Schools
University Of Minnesota Medical School
University Of Colorado University Hospital Program
Conditions Treated
- Hyperlipidemia
- Hyperparathyroidism
- Hypoparathyroidism
- Osteoporosis
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- Elected Member
Education
-
University of Colorado -
University of Minnesota Medical School
Hospital
-
University of Colorado Hospital
Helpful Reviews
Similar Doctors
|
Dr. Romana M. Haas, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. William T. Donahoo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles A. Shuman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emily B. Schroeder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald Valdivieso, MD |
|
|
Dr. John J. Orrego, MD
This Doctor is OpenDoctor Recommended.
|